Trial Profile
Effect of rosiglitazone, compared to sulphonylurea, on endothelial function in Chinese patients with type two diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2008
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary) ; Glibenclamide; Gliclazide; Sulfonylureas
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 25 Apr 2007 New trial record.